165 related articles for article (PubMed ID: 37979056)
1. Comparing histology between prostate cognitive fusion targeted biopsy and radical prostatectomy: exploring risk factors of Gleason score upgrading in Chinese patients.
Zheng T; Sun H; Tang Y; Bi K; Zeng Y; Wang J; Yan L
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18029-18037. PubMed ID: 37979056
[TBL] [Abstract][Full Text] [Related]
2. Analysis of risk factors for Gleason score upgrading after radical prostatectomy in a Chinese cohort.
Zhang B; Wu S; Zhang Y; Guo M; Liu R
Cancer Med; 2021 Nov; 10(21):7772-7780. PubMed ID: 34528767
[TBL] [Abstract][Full Text] [Related]
3. Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation.
He B; Chen R; Gao X; Ren S; Yang B; Hou J; Wang L; Yang Q; Zhou T; Zhao L; Xu C; Sun Y
Oncotarget; 2016 Mar; 7(13):17275-85. PubMed ID: 26943768
[TBL] [Abstract][Full Text] [Related]
4. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
[TBL] [Abstract][Full Text] [Related]
5. Cognitive fusion-targeted biopsy versus transrectal ultrasonography-guided systematic biopsy: comparison and analysis of the risk of Gleason score upgrading.
Zheng T; Bi K; Tang Y; Zeng Y; Wang J; Yan L
Int Urol Nephrol; 2024 Mar; 56(3):981-988. PubMed ID: 37875704
[TBL] [Abstract][Full Text] [Related]
6. From Cognitive MR-Targeted Fusion Prostate Biopsy to Radical Prostatectomy: Incidence and Predictors of Gleason Grade Group Upgrading in a Chinese Cohort.
Yan H; Wu Y; Cui X; Zheng S; Zhang P; Li R
Biomed Res Int; 2022; 2022():7944342. PubMed ID: 36033582
[TBL] [Abstract][Full Text] [Related]
7. [Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy].
Zuo Q; Zhang F; Huang Y; Ma LL; Lu M; Lu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):603-606. PubMed ID: 29263497
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Gleason score upgrading in a large African-American population.
Vora A; Large T; Aronica J; Haynes S; Harbin A; Marchalik D; Nissim H; Lynch J; Bandi G; McGeagh K; Kowalczyk K; Ghasemian R; Venkatesan K; Verghese M; Hwang J
Int Urol Nephrol; 2013 Oct; 45(5):1257-62. PubMed ID: 23864415
[TBL] [Abstract][Full Text] [Related]
9. Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6.
Song W; Bang SH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Kim CK; Lee HM
Clin Genitourin Cancer; 2018 Aug; 16(4):281-287. PubMed ID: 29550198
[TBL] [Abstract][Full Text] [Related]
10. Predicting Gleason sum upgrading from biopsy to radical prostatectomy pathology: a new nomogram and its internal validation.
Wang X; Zhang Y; Zhang F; Ji Z; Yang P; Tian Y
BMC Urol; 2021 Jan; 21(1):3. PubMed ID: 33407381
[TBL] [Abstract][Full Text] [Related]
11. Prediction model of gleason score upgrading after radical prostatectomy based on a bayesian network.
Wang G; Wang X; Du H; Wang Y; Sun L; Zhang M; Li S; Jia Y; Yang X
BMC Urol; 2023 Oct; 23(1):159. PubMed ID: 37805462
[TBL] [Abstract][Full Text] [Related]
12. Prostate Health Index (
Yan JQ; Huang D; Huang JY; Ruan XH; Lin XL; Fang ZJ; Gao Y; Jiang HW; Wu YS; Na R; Xu DF
Asian J Androl; 2022; 24(4):406-410. PubMed ID: 34782549
[TBL] [Abstract][Full Text] [Related]
13. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
[TBL] [Abstract][Full Text] [Related]
15. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.
Epstein JI; Feng Z; Trock BJ; Pierorazio PM
Eur Urol; 2012 May; 61(5):1019-24. PubMed ID: 22336380
[TBL] [Abstract][Full Text] [Related]
16. Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer.
Gondo T; Poon BY; Matsumoto K; Bernstein M; Sjoberg DD; Eastham JA
BJU Int; 2015 Jan; 115(1):81-6. PubMed ID: 24725760
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of "regression to the mean" using routine clinical features with correlating biochemical relapse rates.
Altok M; Troncoso P; Achim MF; Matin SF; Gonzalez GN; Davis JW
Asian J Androl; 2019; 21(6):598-604. PubMed ID: 31115364
[TBL] [Abstract][Full Text] [Related]
18. Gleason sum upgrading between biopsy and radical prostatectomy in Chinese population: Updated nomograms.
Xu H; Bai PD; Hu MB; Mao SH; Zhu WH; Hu JM; Liu SH; Yang T; Hou JY; Hu Y; Ding Q; Jiang HW
Actas Urol Esp; 2017 Apr; 41(3):162-171. PubMed ID: 27522521
[TBL] [Abstract][Full Text] [Related]
19. Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system.
Alqahtani S; Wei C; Zhang Y; Szewczyk-Bieda M; Wilson J; Huang Z; Nabi G
Sci Rep; 2020 May; 10(1):7722. PubMed ID: 32382097
[TBL] [Abstract][Full Text] [Related]
20. Concordance between Gleason score of prostate biopsies and radical prostatectomy specimens and its predictive factors.
Ariafar A; Rezaeian A; Zare A; Zeighami S; Hosseini SH; Nikbakht HA; Narouie B
Urologia; 2023 May; 90(2):236-243. PubMed ID: 35972023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
